[Effect of Dantrium on spasticity in paraplegic and tetraplegic patients (author's transl)].
D000293:Adolescent; D000328:Adult; D003620:Dantrolene / Q000009:adverse effects / Q000627:therapeutic use*; D004341:Drug Evaluation; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009125:Muscle Relaxants, Central / Q000627:therapeutic use*; D009128:Muscle Spasticity / Q000188:drug therapy* / Q000209:etiology; D010264:Paraplegia / Q000150:complications / Q000188:drug therapy*; D011782:Quadriplegia / Q000150:complications / Q000188:drug therapy*
D009125:Muscle Relaxants, Central; D003620:Dantrolene
Effekt van Dantrium op de spasticiteit bij para- en tetraplegie patiënten.